Posted by Michael Wonder on 08 Feb 2017
Decision relating to nicotine replacement therapy RFP
8 February 2017 - PHARMAC has decided to not accept any proposal in response to, and to terminate the process for, the Request for Proposals – Supply of Nicotine Replacement Therapy (NRT) dated 9 November 2016.
The terminology used in the RFP in relation to the request for “sample” packs created clear misunderstanding, with one or more suppliers believing that a level of tracking and follow-up would be required by the supplier for product sampling.
This was not the intention and PHARMAC’s requirement for a small pack size was to allow patients to trial the different types and flavours (where relevant) of NRT treatments without needing to take home a bulk pack of each.
